Race, Ethnicity, Ancestry, and Pharmacogenetics

被引:32
作者
Urban, Thomas J. [1 ]
机构
[1] Duke Univ, Durham, NC 27710 USA
来源
MOUNT SINAI JOURNAL OF MEDICINE | 2010年 / 77卷 / 02期
关键词
ethnicity; genome-wide association studies; pharmacogenetics; race; CONGESTIVE-HEART-FAILURE; GENETIC-VARIATION; DRUG RESPONSE; HEPATITIS-C; ISOSORBIDE DINITRATE; THERAPY; STRATIFICATION; HYDRALAZINE; ASSOCIATION; CLEARANCE;
D O I
10.1002/msj.20168
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pharmacogenetics is the study of how genetic variation influences the response to drugs. The concepts of race, ethnicity, and ancestry have long had a strong influence on pharmacogenetic discovery and on our understanding of population-level differences in drug response. The primary goal of pharmacogenetics, however, is to identify the individual genetic determinants of drug activity so that therapy can be tailored to the individual patient. This article describes the relationship between the concepts of race, ethnicity, and ancestry and how these concepts have been applied to pharmacogenetics, and it provides examples of the benefits and pitfalls associated with the use of racial or ethnic labels in genetic studies. The future of pharmacogenetics, including the study of rare genetic variation and what this means for racial or ethnic disparities in pharmacogenetic discovery, is also discussed. Mt Sinai J Med 77:133-139, 2010. (C) 2010 Mount Sinai School of Medicine
引用
收藏
页码:133 / 139
页数:7
相关论文
共 28 条
[1]   Demonstrating stratification in a European American population [J].
Campbell, CD ;
Ogburn, EL ;
Lunetta, KL ;
Lyon, HN ;
Freedman, ML ;
Groop, LC ;
Altshuler, D ;
Ardlie, KG ;
Hirschhorn, JN .
NATURE GENETICS, 2005, 37 (08) :868-872
[2]  
Cann HM, 2002, SCIENCE, V296, P261
[3]  
Carson P, 1999, J Card Fail, V5, P178, DOI 10.1016/S1071-9164(99)90001-5
[4]   EFFECT OF VASODILATOR THERAPY ON MORTALITY IN CHRONIC CONGESTIVE-HEART-FAILURE - RESULTS OF A VETERANS-ADMINISTRATION COOPERATIVE STUDY [J].
COHN, JN ;
ARCHIBALD, DG ;
ZIESCHE, S ;
FRANCIOSA, JA ;
HARSTON, WE ;
TRISTANI, FE ;
DUNKMAN, WB ;
JACOBS, W ;
FRANCIS, GS ;
FLOHR, KH ;
GOLDMAN, S ;
COBB, FR ;
SHAH, PM ;
SAUNDERS, R ;
FLETCHER, RD ;
LOEB, HS ;
HUGHES, VC ;
BAKER, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (24) :1547-1552
[5]   A COMPARISON OF ENALAPRIL WITH HYDRALAZINE ISOSORBIDE DINITRATE IN THE TREATMENT OF CHRONIC CONGESTIVE-HEART-FAILURE [J].
COHN, JN ;
JOHNSON, G ;
ZIESCHE, S ;
COBB, F ;
FRANCIS, G ;
TRISTANI, F ;
SMITH, R ;
DUNKMAN, WB ;
LOEB, H ;
WONG, ML ;
BHAT, G ;
GOLDMAN, S ;
FLETCHER, RD ;
DOHERTY, J ;
HUGHES, CV ;
CARSON, P ;
CINTRON, G ;
SHABETAI, R ;
HAAKENSON, C .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (05) :303-310
[6]   HLA-B☆5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin [J].
Daly, Ann K. ;
Donaldson, Peter T. ;
Bhatnagar, Pallav ;
Shen, Yufeng ;
Pe'er, Itsik ;
Floratos, Aris ;
Daly, Mark J. ;
Goldstein, David B. ;
John, Sally ;
Nelson, Matthew R. ;
Graham, Julia ;
Park, B. Kevin ;
Dillon, John F. ;
Bernal, William ;
Cordell, Heather J. ;
Pirmohamed, Munir ;
Aithal, Guruprasad P. ;
Day, Christopher P. .
NATURE GENETICS, 2009, 41 (07) :816-U71
[7]   Ethnic differences in pharmacogenetically relevant genes [J].
Engen, R. M. ;
Marsh, S. ;
Van Booven, D. J. ;
McLeod, H. L. .
CURRENT DRUG TARGETS, 2006, 7 (12) :1641-1648
[8]   Drug therapy - Pharmacogenomics - Drug disposition, drug targets, and side effects [J].
Evans, WE ;
McLeod, HL .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (06) :538-549
[9]   Pharmacogenetic testing of CYP2C9 and VKORC1 alleles for warfarin [J].
Flockhart, David A. ;
O'Kane, Dennis ;
Williams, Marc S. ;
Watson, Michael S. ;
Flockhart, David A. ;
Gage, Brian ;
Gandolfi, Roy ;
King, Richard ;
Lyon, Elaine ;
Nussbaum, Robert ;
O'Kane, Dennis ;
Schulman, Kevin ;
Veenstra, David ;
Williams, Marc S. ;
Watson, Michael S. .
GENETICS IN MEDICINE, 2008, 10 (02) :139-150
[10]   Looking for race in all the wrong places: analyzing the lack of productivity in the ongoing debate about race and genetics [J].
Foster, Morris W. .
HUMAN GENETICS, 2009, 126 (03) :355-362